Position in PRQR
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$299,878
-$51,447 QoQ
Shares Held
185,110
+6.4% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRQR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. PRQR ranks #275 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in PRQR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $299,878 | 185,110 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $351,325 | 173,924 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $253,891 | 119,198 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $243,163 | 119,198 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $126,151 | 94,851 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $216,727 | 81,784 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $133,156 | 73,163 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $121,450 | 73,163 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $252,145 | 110,107 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $154,940 | 78,253 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $140,839 | 108,338 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $250,267 | 154,486 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $325,742 | 152,931 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $119,750 | 32,365 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $24,070 | 32,353 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $26,846 | 34,507 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,702 | 19,561 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,505,046 | 187,896 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $622,209 | 74,338 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,905 | 1,618 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $146,537 | 22,169 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $13,750 | 3,274 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $117,594 | 24,550 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||